Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Authors
Tannock I.F. 1 , Fizazi K. 1 , Ivanov S. 1 , Thellenberg Karlsson 1 , Flechon A. 1 , Skoneczna I. 1 , Orlandi F. 1 , Gravis G. 1 , Matveev V. 1 , Bavbek S. 1 , Gil T. 1 , Viana L. 1 , Aren O. 1 , Karyakin O. 1 , Elliott T. 1 , Birtle A. 1 , Magherini E. 1 , Hatteville L. 1 , Petrylak D. 1 , Tombal B. 1 , Rosenthal M. 1
Journal
The Lancet Oncology
Issue number
8
Language
English
Pages
760-768
State
Published
Volume
V14
Year
2013
Organizations
  • 1 Peoples Friendship University of Russia
Cite
ГОСТ MLA RIS BibTex
Share

Other records